SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-233447
Filing Date
2023-09-12
Accepted
2023-09-12 16:05:55
Documents
16
Period of Report
2023-09-11
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d898216d8k.htm   iXBRL 8-K 30637
2 EX-1.1 d898216dex11.htm EX-1.1 192916
3 EX-4.1 d898216dex41.htm EX-4.1 64464
4 EX-5.1 d898216dex51.htm EX-5.1 13989
8 GRAPHIC g898216dsp62.jpg GRAPHIC 3393
  Complete submission text file 0001193125-23-233447.txt   509949

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA cbay-20230911.xsd EX-101.SCH 2850
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbay-20230911_lab.xml EX-101.LAB 17994
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbay-20230911_pre.xml EX-101.PRE 11261
10 EXTRACTED XBRL INSTANCE DOCUMENT d898216d8k_htm.xml XML 3353
Mailing Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560
Business Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36500 | Film No.: 231250132
SIC: 2834 Pharmaceutical Preparations